Inspra Helps, Natrecor Useless for Heart Patients
By wchung | 21 Apr, 2026
There’s good news for millions of people with mild or moderate heart failure. Studies show that the Pfizer drug Inspra and an implanted device from Medtronic can boost survival and cut down on trips to the hospital.
However, another drug that has been used for nearly a decade, Johnson & Johnson’s Natrecor (NAY’-treh-kor), did little to help people with severe heart failure in a study aimed at resolving safety concerns. Doctors say the drug seems safe but does not markedly help shortness of breath or save lives.
The studies were presented Sunday at an American Heart Association conference in Chicago.
MARILYNN MARCHIONE, AP Medical Writer CHICAGO
Recent Articles
- Anterior to the Heart
- Meta to Capture Employee Mouse Movements, Keystrokes for AI Training
- Judge Blocks Trump Policies Stymying Solar, Wind Projects
- Thousands of Companies File Refund Claims As Tariff Refund System Opens
- Volkswagen to Cut Another 1 Million from Annual Capacity
- China's Changan Aims to Join World's top-10 Carmakers by 2030
- Great Wall Motor to Launch 10 New Cars for European Comeback
- Taiwan Exports Orders Surge to Fastest Pace in Over 16 Years
- Many Americans Question Trump’s Temperament
- COVID Shots, Newer Vaccines in Limbo After Court Dinged Kennedy’s Advisory Panel